Cite
HARVARD Citation
Lin, H. et al. (n.d.). ALBI Grade Determines Post‐progression Survivals after Sorafenib Treatment Failure in Advanced HCC Patients: A Model for Second‐Line Trial Selection. American journal of gastroenterology. p. . [Online].